Low-Dose Oral Minoxidil Monitoring Questioned - Summary - MDSpire
From the Journals

Low-Dose Oral Minoxidil Monitoring Questioned

A retrospective hair clinic study found stable blood pressure, heart rate, weight, and laboratory measures during follow-up of up to 30 months.

  • By

  • Kathryn Wighton

  • May 14, 2026

  • 6 min

Share

A recent retrospective study from the United Kingdom suggested that routine monitoring of blood pressure, heart rate, weight, and renal and liver function is generally unnecessary for asymptomatic patients with normal baseline profiles receiving low-dose oral minoxidil for hair loss. The study reviewed data from 74 female patients over up to 30 months, reporting adverse effects like hypertrichosis and dizziness in some cases. While the findings indicate low-dose minoxidil is well-tolerated, the authors recommend individualized monitoring for those with renal impairment or cardiovascular issues.

Original Source(s)

Low-Dose Oral Minoxidil Monitoring Questioned

  • by Kathryn Wighton

  • May 14, 2026

Related Content

Why FDA Said No to a Melanoma Drug

Questions over trial design and political pressure shadowed the rejection of Replimune’s RP1 treatment.

Guselkumab Shows Psoriasis Benefit in Darker Skin Tones

Randomized trial suggests sustained clearance across darker skin tones.

AOPT Plus Collagen May Ease Rosacea

Randomized trial suggests better short-term outcomes and lower recurrence at 24 weeks